Literature DB >> 10333370

Homocysteine--a pathophysiological cornerstone in obstetrical and gynaecological disorders?

R Obwegeser1, M Hohlagschwandtner, H Sinzinger.   

Abstract

Homocysteine, a product of the methionine cycle, is known to play an important role in cardiovascular diseases, neurological disorders and embryology, and in very important, fast growing fields concerning obstetrics and gynaecology. Therefore, we attempted an actual overview on possible obstetrical and gynaecological disorders as a consequence of an impaired methionine cycle. We tried to evaluate all mechanisms concerning homocysteine metabolism in order to look for hypothetical possibilities of therapeutic interventions. Using MEDLINE starting in January 1966, a search was conducted for articles published in which homocysteine was included as a subject heading or a text word. This search was also specified in combination with other key words such as obstetrics, pregnancy, gynaecology and cancer. Additional sources were identified through cross-referencing. All sources found were examined with regard to providing substantial information on our topic. The information obtained was divided into articles dealing with homocysteine and the methionine cycle itself, homocysteine and pregnancy, and homocysteine and hormones, including menopause, hormone replacement therapy and oral contraceptives. Another group was concerned with other special gynaecological aspects of the methionine cycle. We suggest that elevated concentrations of homocysteine could be a marker and perhaps a cause of, or contributive to, a wide range of obstetrical and gynaecological disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333370     DOI: 10.1093/humupd/5.1.64

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  4 in total

1.  Genetic association studies of endothelial nitric oxide synthase gene polymorphisms in women with unexplained recurrent pregnancy loss: a systematic and meta-analysis.

Authors:  Yunlei Cao; Zhaofeng Zhang; Jianhua Xu; Jian Wang; Wei Yuan; Yueping Shen; Jing Du
Journal:  Mol Biol Rep       Date:  2014-02-23       Impact factor: 2.316

2.  Risk of Recurrent Pregnancy Loss in the Ukrainian Population Using a Combined Effect of Genetic Variants: A Case-Control Study.

Authors:  Eleni M Loizidou; Anastasia Kucherenko; Pavlo Tatarskyy; Sergey Chernushyn; Ganna Livshyts; Roman Gulkovskyi; Iryna Vorobiova; Yurii Antipkin; Oleksandra Gorodna; Marika A Kaakinen; Inga Prokopenko; Ludmila Livshits
Journal:  Genes (Basel)       Date:  2021-01-05       Impact factor: 4.096

3.  Polymorphisms of Genes Involved in the Folate Metabolic Pathway Impact the Occurrence of Unexplained Recurrent Pregnancy Loss.

Authors:  Li Luo; Yueming Chen; Li Wang; Guangchao Zhuo; Chunning Qiu; Qiaofeng Tu; Jin Mei; Wen Zhang; Xia Qian; Xianjun Wang
Journal:  Reprod Sci       Date:  2014-12-28       Impact factor: 3.060

4.  Variants c.677 C>T, c.1298 A>C in MTHFR, and c.66 A>G in MTRR Affect the Occurrence of Recurrent Pregnancy Loss in Chinese Women.

Authors:  Yan Zhang; Wenli Zhan; Qianyi Du; Li Wu; Hongke Ding; Fenghua Liu; Aihua Yin
Journal:  Genet Test Mol Biomarkers       Date:  2020-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.